Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...
Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...
Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Program for Hepatitis C Virus (HCV)Patient Enrollment in Global Phase 3 HCV ...
In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...
Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical ...
Migliaccio & Rathod is investigating a recent recall of the Accolade Pacemaker produced by Boston Scientific. If you have one of these pacemakers we would like to speak with you. Please complete the ...
A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...
Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results